Richard H. Williams

Filings by Richard H. Williams span 2 companies, the busiest being Iris International Inc and Anixa Biosciences Inc. Over a trading history stretching from 1 May 2006 to 9 April 2018, the count stands at 52 filings.

Both buying and selling appear: 9 purchases worth €193k, against 31 sales worth €619k. On balance, insiders were net sellers of €426k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants and 3 option exercises. 2018 to date brings no purchases and 1 sale.

The median purchase comes to €16k.

On 11 April 2018 came the latest disclosure, an open-market sale for €94k in Anixa Biosciences Inc. The last purchase on record was published on 15 March 2007, which is 7,178 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.